When Do Employers Drug Test?

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026

Quick answer: Testing clusters at four moments: post-offer/pre-start (most common), during random pools for safety roles, after incidents, and on reasonable suspicion of impairment.

Pre-employment (the default)

Most screens run AFTER a conditional offer — that's why offer letters say 'contingent on background and drug screening.' Timing between offer and start date typically allows 3–7 days.

Random pools

DOT industries must randomly test 25% of safety-sensitive employees annually (50% for alcohol in some modes); names come from computerized pools so nobody schedules their own draw.

Post-incident & suspicion

Workplace accidents triggering medical treatment beyond first aid commonly mandate same-shift collections. Reasonable-suspension testing requires trained supervisor documentation of observed impairment signs.

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)